Outlook Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid in USD from Q4 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Outlook Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q4 2019 to Q2 2025.
  • Outlook Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending June 30, 2025 was $315K, a 15.9% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)

Outlook Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $315K -$59.6K -15.9% Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $334K Mar 31, 2025 10-Q 2025-05-15
Q4 2024 $354K Dec 31, 2024 10-Q 2025-02-14
Q3 2024 $373K Sep 30, 2024 10-K 2024-12-27
Q2 2024 $375K Jun 30, 2024 10-Q 2024-08-14
Q1 2023 $3.95K -$47.3K -92.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $15.8K -$47K -74.8% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $27.7K -$46.7K -62.8% Sep 30, 2022 10-K 2022-12-29
Q2 2022 $39.5K -$46.3K -53.9% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $51.3K Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $62.8K -$83.4K -57.1% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $74.3K -$121K -61.9% Sep 30, 2021 10-K 2021-12-23
Q2 2021 $85.8K -$144K -62.7% Jun 30, 2021 10-Q 2021-08-13
Q4 2020 $146K -$166K -53.2% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $195K Sep 30, 2020 10-K 2020-12-23
Q2 2020 $230K Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $272K Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $312K Dec 31, 2019 10-Q 2020-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.